Measurement of Severe Acute Respiratory Syndrome Coronavirus 2 Antigens in Plasma of Pediatric Patients With Acute Coronavirus Disease 2019 or Multisystem Inflammatory Syndrome in Children Using an Ultrasensitive and Quantitative Immunoassay . (25th February 2022)

• Record Type: Journal Article
• Authors: Sigal, George B; Novak, Tanya; Mathew, Anu; Chou, Janet; Zhang, Yubo; Manjula, Navaratnam; Bathala, Pradeepthi; Joe, Jessica; Padmanabhan, Nikhil; Romero, Daniel; Allegri-Machado, Gabriella; Joerger, Jill; Loftis, Laura L; Schwartz, Stephanie P; Walker, Tracie C; Fitzgerald, Julie C; Tarquinio, Keiko M; Zinter, Matt S; Schuster, Jennifer E; Halasa, Natasha B; Cullimore, Melissa L; Maddux, Aline B; Staat, Mary A; Irby, Katherine; Flori, Heidi R; Coates, Bria M; Crandall, Hillary; Gertz, Shira J; Randolph, Adrienne G; Pollock, Nira R
• Is Part Of: Clinical infectious diseases. Volume 75:Number 8(2022)
• Page Start: 1351
• Page End: 1358
• Publication Date: 2022-02-25
• Subjects: SARS-CoV-2 -- COVID-19 -- antigen -- ultrasensitive immunoassay -- antigenemia; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciac160
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: Background: Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens in blood has high sensitivity in adults with acute coronavirus disease 2019 (COVID-19), but sensitivity in pediatric patients is unclear. Recent data suggest that persistent SARS-CoV-2 spike antigenemia may contribute to multisystem inflammatory syndrome in children (MIS-C). We quantified SARS-CoV-2 nucleocapsid (N) and spike (S) antigens in blood of pediatric patients with either acute COVID-19 or MIS-C using ultrasensitive immunoassays (Meso Scale Discovery). Methods: Plasma was collected from inpatients (<21 years) enrolled across 15 hospitals in 15 US states. Acute COVID-19 patients (n = 36) had a range of disease severity and positive nasopharyngeal SARS-CoV-2 RT-PCR within 24 hours of blood collection. Patients with MIS-C (n = 53) met CDC criteria and tested positive for SARS-CoV-2 (RT-PCR or serology). Controls were patients pre–COVID-19 (n = 67) or within 24 hours of negative RT-PCR (n = 43). Results: Specificities of N and S assays were 95–97% and 100%, respectively. In acute COVID-19 patients, N/S plasma assays had 89%/64% sensitivity; sensitivities in patients with concurrent nasopharyngeal swab cycle threshold (Ct) ≤ 35 were 93%/63%. Antigen concentrations ranged from 1.28–3844 pg/mL (N) and 1.65–1071 pg/mL (S) and correlated with disease severity. In MIS-C, antigens were detected in 3/53 (5.7%) samples (3 N-positive: 1.7, 1.9, 121.1 pg/mL; 1 S-positive: 2.3 pg/mL); the patient with highest N had positive nasopharyngeal RT-PCR (Ct 22.3) concurrent with blood draw. Conclusions: Ultrasensitive blood SARS-CoV-2 antigen measurement has high diagnostic yield in children with acute COVID-19. Antigens were undetectable in most MIS-C patients, suggesting that persistent antigenemia is not a common contributor to MIS-C pathogenesis. Abstract : In a U.S. pediatric cohort tested with ultrasensitive immunoassays, severe acute respiratory syndrome coronavirus 2 nucleocapsid antigens were detectable in most patients with acute coronavirus disease 2019, and spike antigens were commonly detectable. Both antigens were undetectable in almost all multisystem inflammatory syndrome in children patients.